← All organizations
Highest phase reached
Phase 1
First clinical trial
Mar 14, 2019Last known activity
Jun 25, 2024
Timeline
2010s
- Apr 1, 2016
Thrombolex, Inc.— Founded
Drugs by trial phase (1 distinct, 3 trials)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT06433011Lead sponsorN/AJun 25, 2024
- NCT06433011OfficialN/AJun 25, 2024
- NCT04248868Lead sponsorN/AJun 23, 2020
- NCT04248868Overall official - principal investigatorN/AJun 23, 2020
- NCT03927508Lead sponsorPhase 1Mar 14, 2019
Details
- Founded
- Doylestown, PA, US Apr 1, 2016
- Last known activity
- Jun 25, 2024